Navigation Links
FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
Date:3/31/2011

SAN DIEGO, March 31, 2011 /PRNewswire/ -- Polaris Group (Polaris) today announced that the U.S. Food & Drug Administration (FDA) has approved the company's Special Protocol Assessment (SPA) for a Phase 3 clinical trial of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced hepatocellular carcinoma (HCC). The randomized, placebo-controlled, global trial will enroll approximately 600 patients who have failed prior systemic chemotherapy. The primary endpoint of the study is overall survival.

Ghassan Abou-Alfa, M.D., of Memorial Sloan-Kettering Cancer Center in New York, is the principal investigator of the study.  

"ADI-PEG 20 has demonstrated medical benefit in prior studies in multiple indications with a remarkable safety profile," said Dr. Abou-Alfa. "I am delighted to lead this study to explore ADI-PEG 20 as a viable option for patients with advanced liver malignancies."

SPA is a mechanism that allows the FDA and drug developers to reach an agreement prior to study initiation about the design and size of a Phase 3 trial. It will form the primary basis of an efficacy claim in a marketing application.

"The SPA agreement with the FDA is a key step in our plans for the clinical development of ADI-PEG 20," said John Bomalaski, M.D., executive vice president, medical affairs, of Polaris. "We are pleased to move ADI-PEG 20 into a pivotal Phase 3 trial and to be working with such well-established hepatocellular carcinoma experts."

Leo Chen, M.D., the lead investigator of the Phase 2 HCC study in Taiwan, stated, "Our Phase 2 study demonstrated that ADI-PEG 20 was effective and well-tolerated in patients with advanced liver cancer, and we look forward to the opportunity to further assess the efficacy and safety of this drug in a large randomized Phase 3 study."

The lead investigator in China, Shukui Qin, M.D., president of the Chinese Society of Clinical Oncology and chair of the Chinese Liver Cancer Stu
'/>"/>

SOURCE Polaris Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
2. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
3. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
4. FDA Approves Gadavist for Central Nervous System Scans
5. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
6. FDA Approves Device to Maintain Blood Flow During Artery Bypass Brain Surgery
7. FDA Approves BENLYSTA® for Lupus in Breakthrough for Millions of Sufferers
8. FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD
9. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
10. FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
11. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014 Scott Steiger ... most of the world. As an engineer for the past 20 ... member of the military service. He,s been to six of the ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... for travelers, he has a pretty good idea of what,s required. ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... , Nov. 26, 2014 The ... at a rate of 4%, with world market ... Kalorama Information. MRI and other types of medical ... and treatment of numerous medical conditions in children ... and techniques. Kalorama,s report, Medical Imaging Markets ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
(Date:11/28/2014)... 2014 Recently, PrettyTailor.com has developed and ... its customers around the world in celebration of the ... has also launched a special offer on all these ... As a pioneer in the garment industry, PrettyTailor.com brings ... clients large and small. The business carries quite a ...
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 The month ... over 20,000 car accidents occurring in Florida every year ... on the importance of auto insurance policies. , "Optional auto ... drop. Auto insurance is not cheap I know, actually Florida ... the costs are even higher, but what I see is ...
(Date:11/28/2014)... FRIDAY, Nov. 28, 2014 (HealthDay News) -- People with diabetes ... planning can help keep you healthy, an expert says. ... how you,ll deal with the events, the family you,ll be ... the American Association of Diabetes Educators, said in an association ... and still be healthy." One idea is to make ...
(Date:11/28/2014)... MA (PRWEB) November 28, 2014 Agein.com, the ... and advice from some of the foremost experts in the ... for preventing dry skin this winter. , “The official start ... North America has already been hit with an icy blast. ... many are wondering if 2015 will usher in another brutal ...
(Date:11/28/2014)... BambooFlooringChina.com has been recognized as a ... the business has announced its new strand woven ... discount on these new models. , Based on the ... without carpenter machines involved. It is crafted on strand ... for do-it-yourselfers without hard work on installation, also available ...
Breaking Medicine News(10 mins):Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2Health News:Holiday Eating Tips for People With Diabetes 2Health News:Agein Corporation, a Leading Anti-Aging Company, Releases Top Diet and Personal Care Tips for Preventing Dry Skin this Season 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2
... , Key Highlights, Misys plc (LSE: MSY) ... for the next phase of the turnaround. Misys generated ... to GBP81m,37% ahead of last year. Misys is executing ... the turnaround plan, building a platform for growth., ...
... Wake Forest University Baptist Medical Center demonstrates emergency room ... heart attack, even when laboratory tests haven,t yet confirmed ... called i*trACS, and analyzed patients with heart attack symptoms ... participating U.S. centers. , The findings were released ...
... and Naturalization ready at Passport ... ... vaccine requirements will affect,anyone who is applying for an immigrant visa ... permanent residence. Applicants,must show proof of vaccinations against vaccine-preventable diseases, as,recommended ...
... in scrotum boosts sperm count, motility, study finds , , ... invasive procedure can treat a common cause of male ... baby, a new study finds. , The condition, called ... the scrotum which prevents the normal circulation of blood ...
... LOS ANGELES, July 23 Times may be tough, ... nothing like,a dazzling new smile to boost confidence. Cosmetic ... in on success, citing his,experience that a beautiful smile ... agreement is Landon Brown, who is now sporting a ...
... person had heart trouble, the worse their performance , , WEDNESDAY, ... coronary heart disease seem to fare worse on measures of ... heart disease, the worse the performance in such mental processes ... in the July 23 issue of the European Heart ...
Cached Medicine News:Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Coronary Disease Dulls Cognitive Skills 2
... Infinity Triglycerides powder reagent once reconstituted ... of single liquid stability to help ... and provide quick result turnaround time. ... Triglycerides powder reagent provides a long ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The patented ... provides a long shelf life that ...
... Infinity Creatinine single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Creatinine reagent provides a long shelf ...
... Amylase powder reagent once reconstituted offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... powder reagent provides a long shelf ...
Medicine Products: